SIFI SpA-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:SIFI SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013260
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SIFI SpA (SIFI) is an integrated ophthalmic company that focuses on eye care products. It develops, manufactures and markets pharmaceutical products, diagnostic instruments and surgical equipment for the prevention and treatment of the most common ocular pathologies. SIFI develops its products in various dosage forms including ointments, eye drops, pills and capsules. Its products find application in the areas of corneal abrasions, cataract, glaucoma, infections, inflammation, dry eye, and retinopathies. It conducts research in the areas of diagnostics and surgery. SIFI has subsidiaries in Mexico and Romania; and a network of distributors in Russia, Spain, the UK and Turkey. SIFI is headquartered in Catania, Sicilia, Italy.

SIFI SpA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SIFI SpA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
SIFI SpA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
SIFI SpA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
SIFI SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
SIFI SpA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
SIFI SpA, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Alimera Sciences Enters into Distribution Agreement with SIFI for Iluvien 10
SIFI And NovaMedica Enter Into Agreement To Market Eye Care Products 11
Licensing Agreements 12
SIFI Enters into Licensing Agreement with Knight Therapeutics 12
SIFI SpA – Key Competitors 13
SIFI SpA – Key Employees 14
SIFI SpA – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Product News 16
Jan 14, 2016: SIFI announces the expansion of its product portfolio with the return on the Italian market of Colbiocin eye drops 16
Clinical Trials 17
May 27, 2016: SIFI announces the conclusion of Phase I clinical trial for the development of PHMB an orphan drug for the treatment of Acanthamoeba Keratitis, a rare ocular disease 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
SIFI SpA, Pharmaceuticals & Healthcare, Key Facts 2
SIFI SpA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
SIFI SpA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
SIFI SpA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
SIFI SpA, Deals By Therapy Area, 2011 to YTD 2017 8
SIFI SpA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Alimera Sciences Enters into Distribution Agreement with SIFI for Iluvien 10
SIFI And NovaMedica Enter Into Agreement To Market Eye Care Products 11
SIFI Enters into Licensing Agreement with Knight Therapeutics 12
SIFI SpA, Key Competitors 13
SIFI SpA, Key Employees 14
SIFI SpA, Subsidiaries 15

★海外企業調査レポート[SIFI SpA-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Marinus Pharmaceuticals Inc (MRNS):企業の財務・戦略的SWOT分析
    Summary Marinus Pharmaceuticals Inc (Marinus Pharmaceuticals) is a biopharmaceutical company which discovers, develops and commercializes medicines for the treatment of epilepsy and other neuropsychiatric disorders. The company is evaluating its lead product candidate Ganaxolone, a gamma-aminobutyri …
  • Cabot Microelectronics Corp (CCMP):企業の財務・戦略的SWOT分析
    Cabot Microelectronics Corp (CCMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Balfour Beatty plc:企業の戦略・SWOT・財務分析
    Balfour Beatty plc - Strategy, SWOT and Corporate Finance Report Summary Balfour Beatty plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • SM Energy Company:企業の戦略・SWOT・財務情報
    SM Energy Company - Strategy, SWOT and Corporate Finance Report Summary SM Energy Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • U.S. Stem Cell Inc (USRM):企業の財務・戦略的SWOT分析
    U.S. Stem Cell Inc (USRM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sinoma International Engineering Co Ltd:企業の戦略・SWOT・財務情報
    Sinoma International Engineering Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Sinoma International Engineering Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Reliance Industries Ltd (RELIANCE):石油・ガス:M&Aディール及び事業提携情報
    Summary Reliance Industries Ltd (RIL) is a conglomerate with business interests in energy, petrochemicals, textiles, retail, and telecommunication sectors. The company carries out exploration, development and production of oil and gas, refining of crude oil, marketing of petroleum products, and prod …
  • Tsumura & co (4540):企業の財務・戦略的SWOT分析
    Tsumura & co (4540) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Ansell Limited:戦略・SWOT・企業財務分析
    Ansell Limited - Strategy, SWOT and Corporate Finance Report Summary Ansell Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Sumo Group PLC (SUMO):企業の財務・戦略的SWOT分析
    Sumo Group PLC (SUMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Global Business Power Corp:電力:M&Aディール及び事業提携情報
    Summary Global Business Power Corp (GBPC), formerly Mirant Global Corp, a subsidiary of ORIX Corp, is an energy utility that generates and distributes electricity. The utility produces reliable and cost-efficient power supply through its subsidiaries that operate power generation facilities. Its ser …
  • L.L. Bean, Inc.:企業の戦略・SWOT・財務情報
    L.L. Bean, Inc. - Strategy, SWOT and Corporate Finance Report Summary L.L. Bean, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • The Straits Trading Co Ltd:企業の戦略・SWOT・財務情報
    The Straits Trading Co Ltd - Strategy, SWOT and Corporate Finance Report Summary The Straits Trading Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Silgan Holdings Inc.:企業の戦略・SWOT・財務情報
    Silgan Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Silgan Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Al Arrab Contracting Company:企業の戦略的SWOT分析
    Al Arrab Contracting Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • TrustPower Limited:企業の戦略・SWOT・財務分析
    TrustPower Limited - Strategy, SWOT and Corporate Finance Report Summary TrustPower Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Stellar Biotechnologies Inc (SBOT)-医療機器分野:企業M&A・提携分析
    Summary Stellar Biotechnologies Inc (Stellar Bio), formerly CAG Capital Inc is a provider of keyhole limpet hemocyanin proteins. The company offers potent immune-stimulating molecule used as an active pharmaceutical ingredient known as active immunotherapies or therapeutic vaccines and as an injecta …
  • Corporation Bank:企業の戦略・SWOT・財務情報
    Corporation Bank - Strategy, SWOT and Corporate Finance Report Summary Corporation Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Xinjiang Goldwind Science & Technology Co Ltd (002202):企業の財務・戦略的SWOT分析
    Xinjiang Goldwind Science & Technology Co Ltd (002202) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s …
  • United Orthopedic Corp (4129)-医療機器分野:企業M&A・提携分析
    Summary United Orthopedic Corp (UOC) is a medical device company that designs, manufactures and distributes orthopedic implants and instrument sets. The company’s product categories include knee replacement systems, hip replacement systems, and oncology products. Its hip replacement systems include …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆